Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee JJ et al. – The authors demonstrate that fenofibrate can significantly inhibit artery thrombus formation in vivo, which may be due to antiplatelet activity via the inhibition of thromboxane A2 receptor, cytosolic calcium mobilization and COX–1 activity, and the beneficial effect of fenofibrate on cardiovascular system may be also due to its modulation of platelet activation.

Related Articles

Management of bleeding disorders by prohemostatic therapy
International Journal of Hematology, 10/12/09    Relevance Score: 64%

Acute Coronary Syndromes: Diagnosis and Management, Part II
Mayo Clinic Proceedings, 11/03/09    Relevance Score: 63%

Triple-negative breast cancer—current status and future directions
Annals of Oncology, 11/16/09    Relevance Score: 45%

Use of remifentanil as a sedative agent in critically ill adult patients: a meta-analysis
Anaesthesia, 11/11/09    Relevance Score: 45%

The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Therapeutics and Clinical Risk Management, 10/07/09    Relevance Score: 45%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address